Johnson & Johnson PE Ratio 2006-2019 | JNJ

Current and historical p/e ratio for Johnson & Johnson (JNJ) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Johnson & Johnson PE ratio as of September 18, 2019 is 14.90.
Johnson & Johnson PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-09-18 130.41 21.63
2019-06-30 139.28 $6.03 23.10
2019-03-31 139.79 $5.40 25.89
2018-12-31 128.20 $5.61 22.85
2018-09-30 136.39 $0.50 272.79
2018-06-30 118.99 $0.43 276.71
2018-03-31 124.74 $0.38 328.27
2017-12-31 135.14 $0.39 346.52
2017-09-30 124.99 $5.76 21.70
2017-06-30 126.38 $5.92 21.35
2017-03-31 118.20 $5.95 19.87
2016-12-31 108.63 $5.88 18.47
2016-09-30 110.62 $5.65 19.58
2016-06-30 112.83 $5.32 21.21
2016-03-31 99.94 $5.50 18.17
2015-12-31 94.20 $5.49 17.16
2015-09-30 84.98 $5.23 16.25
2015-06-30 88.03 $5.69 15.47
2015-03-31 90.21 $5.59 16.14
2014-12-31 93.12 $5.70 16.34
2014-09-30 94.31 $6.04 15.61
2014-06-30 91.94 $5.42 16.96
2014-03-31 85.73 $5.24 16.36
2013-12-31 79.36 $4.82 16.47
2013-09-30 74.60 $4.50 16.58
2013-06-30 73.34 $4.51 16.26
2013-03-31 69.12 $3.68 18.78
2012-12-31 58.96 $3.87 15.23
2012-09-30 57.45 $3.04 18.90
2012-06-30 55.82 $3.14 17.78
2012-03-31 53.98 $3.64 14.83
2011-12-31 53.20 $3.48 15.29
2011-09-30 51.19 $4.10 12.48
2011-06-30 52.99 $4.18 12.68
2011-03-31 46.79 $4.41 10.61
2010-12-31 48.41 $4.78 10.13
2010-09-30 48.08 $4.87 9.87
2010-06-30 45.40 $4.84 9.38
2010-03-31 49.67 $4.76 10.43
2009-12-31 48.69 $4.40 11.07
2009-09-30 45.67 $4.58 9.97
2009-06-30 42.26 $4.55 9.29
2009-03-31 38.79 $4.57 8.49
2008-12-31 43.76 $4.57 9.57
2008-09-30 50.27 $4.42 11.37
2008-06-30 46.39 $4.13 11.23
2008-03-31 46.44 $4.01 11.58
2007-12-31 47.44 $3.63 13.07
2007-09-30 46.44 $3.55 13.08
2007-06-30 43.27 $3.61 11.99
2007-03-31 42.04 $3.51 11.98
2006-12-31 45.79 $3.73 12.28
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $342.221B $81.581B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Roche Holding AG (RHHBY) Switzerland $240.930B 0.00
Merck (MRK) United States $211.257B 17.37
Pfizer (PFE) United States $201.883B 11.89
Novartis AG (NVS) Switzerland $198.525B 17.07
Novo Nordisk (NVO) Denmark $120.697B 21.33
AstraZeneca (AZN) United Kingdom $113.163B 21.89
Sanofi (SNY) France $110.933B 13.63
Eli Lilly (LLY) United States $107.279B 20.02
AbbVie (ABBV) United States $105.859B 8.48
GlaxoSmithKline (GSK) United Kingdom $102.512B 12.88
Bristol-Myers Squibb (BMY) United States $81.363B 11.54
Bayer (BAYRY) Germany $69.195B 10.08
H Lundbeck (HLUYY) Denmark $6.741B 9.73